1-6 of 6
Sarah J. Hill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations

Venkatesh Pooladanda, Shaan Kumar, Yusuke Matoba, Maryam Azimi Mohammadabadi, Dominique T. Zarrella, Ursula A. Winter, Sarah J. Hill, Hyungsoon Im, Bo R. Rueda
Journal: Cancer Research
Cancer Res (2024) 84 (5_Supplement_2): A113.
https://doi.org/10.1158/1538-7445.OVARIAN23-A113
Published: 04 March 2024
View article titled, Abstract A113: Extracellular vesicles derived from enriched ovarian cancer stem cell fractions promote stem like properties in the more vulnerable tumor cell populations
Journal Articles

Abstract 4309: Early apoptotic measurements of patient-derived organoids predict patient response to therapy

Kelley E. McQueeney, Patrick Bhola, Sarah J. Hill, Anthony Letai
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 4309.
https://doi.org/10.1158/1538-7445.AM2023-4309
Published: 04 April 2023
View article titled, Abstract 4309: Early apoptotic measurements of patient-derived organoids predict patient response to therapy
Journal Articles

Abstract 3459: Drug persistence pathways in ovarian cancer identified by single-cell analysis of patient samples and cell line models

Elizaveta Leshchiner, Richard Panayiotou, Anay Gupta, Thomas Zhang, Kayli Neil, Nomeda Girnius, Aylin Henstridge, Brian P. Danysh, Ignaty Leshchiner, Sarah J. Hill, Laxmi Parida, Ursula A. Matulonis, Joan S. Brugge, Gad Getz
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3459.
https://doi.org/10.1158/1538-7445.AM2023-3459
Published: 04 April 2023
View article titled, Abstract 3459: Drug persistence pathways in ovarian cancer identified by single-cell analysis of patient samples and cell line models
Journal Articles

Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer

Changxin Wan, Matthew P. Keany, Han Dong, Linah F. Al-Alem, Unnati M. Pandya, Suzan Lazo, Karsten Boehnke, Katherine N. Lynch, Rui Xu, Dominique T. Zarrella, Shengqing Gu, Paloma Cejas, Klothilda Lim, Henry W. Long, Kevin M. Elias, Neil S. Horowitz, Colleen M. Feltmate, Michael G. Muto, Michael J. Worley, Jr, Ross S. Berkowitz, Ursula A. Matulonis, Marisa R. Nucci, Christopher P. Crum, Bo R. Rueda, Myles Brown, Xiaole Shirley Liu, Sarah J. Hill
Journal: Cancer Research
Series: Author Choice
Cancer Res (2021) 81 (1): 158–173.
https://doi.org/10.1158/0008-5472.CAN-20-1674
Published: 04 January 2021
View article titled, Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer
Open the PDF for Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract CT232: Phase I combination study of the CHK1 inhibitor prexasertib (LY2606368) and olaparib in patients with high-grade serous ovarian cancer and other advanced solid tumors

Khanh T. Do, Sarah J. Hill, Bose Kochupurakkal, Jeffrey G. Supko, Courtney Gannon, Adrienne Anderson, Alona Muzikansky, Andrew Wolanski, Jennifer Hedglin, Kalindi Parmar, Jean-Bernard Lazaro, Joyce Liu, Susana Campos, Ursula A. Matulonis, Alan D. D'Andrea, Geoffrey I. Shapiro
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT232.
https://doi.org/10.1158/1538-7445.AM2019-CT232
Published: 01 July 2019
View article titled, Abstract CT232: Phase I combination study of the CHK1 inhibitor prexasertib (LY2606368) and olaparib in patients with high-grade serous ovarian cancer and other advanced solid tumors
Journal Articles

Abstract 368A: Functional assessment of DNA damage repair defects and the anti-tumor immune response in high grade serous ovarian cancers using patient-derived organoids

Sarah J. Hill, Patrick Lizotte, Neil S. Horowitz, Michael G. Muto, Michael J. Worley, Colleen M. Feltmate, Bose Kochupurakkal, Khanh T. Do, Panagiotis Konstantinopoulos, Marisa R. Nucci, Joyce F. Liu, Ursula A. Matulonis, Geoffrey I. Shapiro, Ross S. Berkowitz, Christopher P. Crum, Alan D. D'Andrea
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 368A.
https://doi.org/10.1158/1538-7445.AM2019-368A
Published: 01 July 2019
View article titled, Abstract 368A: Functional assessment of DNA damage repair defects and the anti-tumor immune response in high grade serous ovarian cancers using patient-derived organoids